| 1 |
WHO. Hepatitis B Fact Sheets [EB/OL]. 2014.
URL
|
| 2 |
WHO. Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection [EB/OL]. 2015.
URL
|
| 3 |
乙型肝炎病毒感染女性生育管理专家委员会. 乙型肝炎病毒感染女性生育管理专家共识(指南)[J/CD]. 中华实验和临床感染病杂志:电子版,2014,8(1):92-95.
|
| 4 |
Wiseman E, Fraser MA, Holden S, et al. Perinatal transmission of hepatitis B virus:an Australian experience[J]. Med J Aust,2009,190(9):489-492.
|
| 5 |
Yang YJ, Liu CC, Chen TJ et al. Role of hepatitis B immunoglobulin in infants born to hepatitis B e antigennegative carrier mothers in Taiwan[J]. Pediatr Infect Dis J,2003,22(7):584-588.
|
| 6 |
Xu WN, Cui YT, Wang L, et al. Lamivudine in late pregnancy to prevent transmission of hepatitis B virus infecton: a multicentre, randomized, double-blind,placebo-controlled study[J]. J Viral Hepat,2009,16(2):94-103.
|
| 7 |
Lai CL, Ratziu V, Yuen MF, et al. Viral hepatitis B[J]. Lancet,2003,362(9401):2089-2094.
|
| 8 |
夏国良，龚健，王继杰, 等. 重组乙型肝炎疫苗阻断乙型肝炎病毒母婴传播方案的保护效果评价[J]. 中华流行病学杂志,2003,24(5):362-365.
|
| 9 |
Yi W, Liu M, Chen A, et al. The efficacy of lamivudine use in the second vs. third trimester of pregnancy in preventing vertical transmission of HBV in highly viremic mothers[J]. Hepatology,2013;58(1):614.
|
| 10 |
中华医学会肝病学分会，中华医学会感染病学分会. 慢性乙型肝炎防治指南(2015年版) [J/CD]. 中华实验和临床感染病杂志:电子版,2015,9(5):570-589.
|
| 11 |
Pan C, Liu M, Cai H, et al. Safety of tenofovir disoproxil fumarate (TDF) treatment for the entire pregnancy in mothers with active chronic hepatitis B or cirrhosis[J]. Hepatology,2013,58(1):624.
|
| 12 |
Xu YY, Liu HH, Zhong YW, et al. Peripheral blood mononuclear cell traffic plays a crucial role in mother-to-infant transmission of hepatitis B virus[J]. Int J Biol Sci,2015,11(3):266-273.
|
| 13 |
Lin HH, Ohto H, Etoh T, et al. Studies on the risk factors of intrauterine infection of hepatitis B virus[J]. Nihon Sanka Fujinka Gakkai zasshi,1985,37(11):2393-2400.
|
| 14 |
Ohto H, Lin HH, Kawana T, et al. Intrauterine transmission of hepatitis B virus is closely related to placental leakage[J]. J Med Virol,1987,21(1):1-6.
|
| 15 |
Xu DZ, Yan YP, Choi BC, et al. Risk factors and mechanism of transplacental transmission of hepatitis B virus:a case-control study[J]. J Med Virol,2002,67(1):20-26.
|
| 16 |
Bai GQ, Li SH, Yue YF, et al. The study on role of peripheral blood mononuclear cell in HBV intrauterine infection[J]. Arch Gynecol Obstet,2011,283(2):317-321.
|
| 17 |
Murakami Y, Minami M, Daimon Y, et al. Hepatitis B virus DNA in liver,serum,and Peripheral blood mononuclear cells after the clearance of serum hepatitis B virus surface antigen[J]. J Med Virol,2004,72(2):203-214.
|
| 18 |
Lu L, Zhang HY, Yueng YH, et al.Intracellular levels of hepatitis B virus DNA and pregenomic RNA in peripheral blood mononuclear cells of chronically infected patients[J]. J Med Virol,2009,16(2):104-112.
|
| 19 |
魏俊妮，王素萍，双杰玉. 母胎转运与乙型肝炎病毒宫内感染关系的研究[J]. 中华流行病学杂志,2005,26(4):240-244.
|
| 20 |
石磊，岳亚飞，张树林, 等. 新生儿外周血单个核细胞感染乙型肝炎病毒的机制及意义[J]. 中华儿科杂志,2006,44(11):855-858.
|
| 21 |
Li XM, Shi MF, Yang YB, et al. Effect of hepatitis B immunoglobulin on interruption of HBV intrauterine infection[J]. World J Gastroenterol,2004,10(21):3215-3217.
|
| 22 |
Xu Q, Xiao L, Lu XB, et al. A randomized controlled clinical trial:interruption of intrauterine transmission of hepatitis B virus infection with HBIG[J]. Word J Gastroenterol,2006,12(21):3434-3437.
|
| 23 |
Shao QL, Zhao XX, Yao L. Role of peripheral blood mononuclear cell transportation from mother to baby in HBV intrauterine infection[J]. Arch Gynecol Obstet,2013,288(6):1257-1261.
|
| 24 |
Ye F, Jin Y, Kong Y, et al.The presence of HBV mRNA in the fertilized in vitro embryo of HBV patients confirms vertical transmission of HBV via the ovum[J]. Epidemiol Infect,2013,141(5):926-930.
|
| 25 |
Yang J, Zeng X, Men Y, et al. Elective caesarean section versus vaginal delivery for preventing mother to child transmission of hepatitis B virus-a systematic review[J]. Virol J,2008,5(8):100-107.
|
| 26 |
Pol S, Corouge M, Fontaine H. Hepatitis B virus infection and pregnancy[J]. Clin Res Hepatol Gastroenterol,2011,35(10):618-622.
|
| 27 |
Kumar A. Hepatitis B virus infection and pregnancy:apractical approach[J]. Indian J Gastroenterol,2012,31(2):43-54.
|
| 28 |
Pan CQ, Duan ZP, Bhamidimarri KR, et al. An algorithm for risk assessment and intervention of mother to child transmission of hepatitis B virus[J]. Clin Gastroenterol Hepaterol,2012,10(5):452-459.
|
| 29 |
Wong VC, Lee AK, Ip HM. Transmission of hepatitis B antigens from symptom free carrier mothers to the fetus and the infant[J]. Br J Obstet Gynaecol,1980,87(11):958-965.
|
| 30 |
Milich D, Liang TJ. Exploring the biological basis of hepatitis B e antigen in hepatitis B virus infection[J]. Hepatology,2003,38(5):1075-1086.
|
| 31 |
Thompson AJ, Nguyen T, Iser D, et al. Serum hepatitis B surface antigen and hepatitis B e antigen titers: disease phase influences correlation with viral load and intrahepatic hepatitis B virus markers[J]. Hepatology,2010,51(6):1933-1944.
|
| 32 |
Deguchi M, Yamashita N, Kagita M, et al. Quantitation of hepatitis B surface antigen by an automated chemiluminescent microparticle immunoassay[J]. J Virol Methods,2004,115(2):217-222.
|
| 33 |
Demiroren K, Kocamaz H, Doqan Y. The importance of the serum quantitative levels of hepatitis B surface antigen and hepatitis B e antigen in children with chronic hepatitis B[J]. Turk J Gastroenterol,2015,26(1):36-41.
|
| 34 |
Wiseman E, Fraser MA, Holden S, et al. Perinatal transmission of hepatitis B virus:an Australian experience[J]. Med J Aust,2009,190(9):489-92.
|
| 35 |
Zou H, Chen Y, Duan Z, et al. Virologic factors associated with failure to passive-active immunoprophylaxis in infants born to HBsAg-positive mothers[J]. J Viral Hepat,2012,19(2):18-25..
|
| 36 |
Samadi Kochaksaraei G, Congly SE, Matwiy T, et al. Cost effectiveness of quantitative hepatitis B virus surface antigen testing in pregnancy in predicting vertical transmission risk[J]. Liver Int,2016. [Epub ahead of print]
|
| 37 |
Wen WH, Huang CW, Chie WC，et al. Quantitative maternal hepatitis B surface antigen predicts maternally transmitted hepatitis B virus infection[J]. Hepatology,2016. [Epub ahead of print]
|
| 38 |
Pan CQ, Zou HB, Chen Y, et al. Cesarean section reduces perinatal transmission of HBV Infection from hepatitis B surface antigen-positive women to their infants[J]. Clin Gastroenterol Hepatol,2013,11(10):1349-1355.
|
| 39 |
Liu Y, Wang M, Yao S, et al. Efficacy and safety of telbivudine in different trimesters of pregnancy with high viremia for interrupting perinatal transmission of HBV[J]. Hepatol Res,2016,46(3):181-188.
|
| 40 |
Shi Z, Yang Y, Wang H, et al. Breastfeeding of newborns by motherscarrying hepatitis B virus:a meta-analysis and systematicreview[J]. Arch Pediatr Adolesc Med,2011,165(9):837-846.
|
| 41 |
Hill JB, Sheffield JS, Kim MJ, et al. Risk of hepatitis B transmission in breast-fed infants of chronic hepatitis B carriers[J]. Obstet Gynecol,2002,99(6),1049-1052.
|
| 42 |
Sokal EM, Paganelli M, Wirth S, et al. Management of chronichepatitis B in childhood:ESPGHAN clinical practice guidelines:consensus of an expert panel on behalf of the European Society of Pediatric Gastroenterology, Hepatology and Nutrition[J]. J Hepatol,2013,59(4):814-829.
|
| 43 |
Wong VC, Lee AK, Ip HM. Transmission of hepatitis B antigens from symptoms free carrier mothers to the fetus and the infant[J]. Br J Obstet Gynaecol,1980,87(11):958-965.
|
| 44 |
Bzowej NH. Optimal management of the hepatitis B patient who desires pregnancy or is pregnant[J]. Curr Hepatitis Rep,2012,11(2):82-89.
|
| 45 |
Xu YY, Yu JY, Zhong YW, et al. Association between the frequency of class II HLA antigens and the susceptibility to intrauterine infection of hepatitis B virus[J]. Int J Biol Sci,2008,4(2):111-115.
|
| 46 |
Keeffe EB, Dieterich DT, Han SH, et al. A treatment algorithm for the management of chronic hepatitis B virus infection in the United States:2008 update[J]. Clin Gastroenterol Hepatol,2008,6(12):1315-1341.
|
| 47 |
Yu M, Jiang Q, Gu X, et al. Correlation between vertical transmission of hepatitis B virus and the expression of HBsAg in ovarian follicles and placenta[J]. PLoS One,2013,8(1):54246.
|
| 48 |
Zhang SL, Yue YF, Bai GQ, et al. Mechanism of Intrauterine infection of hepatitis B virus[J]. World J Gastroenterology,2004,10(3):437-438.
|
| 49 |
Xu DZ, Yan YP, Choi BC, et al. Risk factors and mechanism of transplacental transmission of hepatitis B virus: a case-control study[J]. J Med Virol,2002,67(1):20-26.
|
| 50 |
Lu LL, Chen BX, Wang J, et al. Maternal transmission risk and antibody levels against hepatitis B virus e antigen in pregnant women[J]. Int J Infect Dis,2014,28(7):41-44.
|